Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses
NCT ID: NCT07030010
Last Updated: 2025-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2025-07-08
2025-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Sugar-free Isotonic Drink on Different Health Bioparameters
NCT06184997
Glucose Tolerance in Healthy Overweight Adults
NCT00974831
Effects of Drink Composition on the Appearance of Ingested Water in Body Fluids
NCT04509388
A Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar on Blood Glucose Control in a Healthy Adult Population
NCT07043478
Zero Calorie Drink Products
NCT00525694
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tonic drink
This arm will receive the tonic drink on their first postprandial challenge
Breakfast meal challenge with tonic drink
High-carbohydrate containing breakfast meal with the addition of the tonic drink
Placebo drink
This arm will receive the placebo drink on their first postprandial challenge
Breakfast meal challenge with placebo drink
High-carbohydrate containing breakfast meal with the addition of the placebo drink
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breakfast meal challenge with tonic drink
High-carbohydrate containing breakfast meal with the addition of the tonic drink
Breakfast meal challenge with placebo drink
High-carbohydrate containing breakfast meal with the addition of the placebo drink
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI) of ≥27.0 kg/m2
Exclusion Criteria
* a BMI less than 27.0 kg/m2,
* have an allergy to any of the components in the plant-based tonic (see section 6),
* pregnant or breastfeeding,
* regularly skipping breakfast (i.e. not consuming breakfast on 5/7 days per week),
* any diagnosed metabolic (e.g. diabetes), endocrine (e.g. hyperthyroidism), gastrointestinal (e.g. Crohn's) or cardiovascular (e.g. heart failure) abnormalities,
* on an energy-restricted diet; significant weight fluctuation in the previous 3 months (\>5% body weight),
* high alcohol consumption (\>14 units/week) (as per Alcohol Drink Guidelines),
* medication that is used to treat blood glucose,
* unable to attend in person testing sessions, or
* unable or unwilling to provide blood samples.
30 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Australian Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonidas Karagounis, PhD
Role: PRINCIPAL_INVESTIGATOR
Australian Catholic University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Australian Catholic University
Melbourne, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-4309HC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.